NCT ID,Brief Title,Official Title,Status,Current Phase,Start Date,Completion Date,Primary Completion Date,Conditions,Interventions,Sponsors,Locations,Study Type,Enrollment,Study Population
NCT02587312,Evaluation of Very Low Nicotine Content Cigarettes in Adolescent Smokers,Evaluation of Very Low Nicotine Content Cigarettes in Adolescent Smokers,COMPLETED,NA,2016-10-13T00:00:00,2019-08-31T00:00:00,2019-08-28T00:00:00,Nicotine Dependence,,Brown University,,INTERVENTIONAL,,
NCT00088881,"Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma",A Phase II Trial of R-CHOP Followed by Zevalin Radioimmunotherapy for Patients With Previously Untreated Stages I and II CD20+ Diffuse Large Cell Non-Hodgkin's Lymphoma,TERMINATED,PHASE2,2004-12-01T00:00:00,2011-03-01T00:00:00,2011-03-01T00:00:00,Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Testicular Lymphoma; Waldenstr√∂m Macroglobulinemia,,National Cancer Institute (NCI),,INTERVENTIONAL,,
NCT06956781,Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD),Optimizing Behavioral Health Services Following Pediatric Trauma Exposure,NOT_YET_RECRUITING,NA,2025-09-01T00:00:00,2028-08-01T00:00:00,2028-08-01T00:00:00,PTSD; Trauma; Pediatric ALL,,University of Rochester,,INTERVENTIONAL,,
NCT01854112,Helical Irradiation of Total Skin (HITS) for T Cell Lymphoma,,UNKNOWN,,2012-11-01T00:00:00,,2017-12-01T00:00:00,T-cell Lymphoma,,Far Eastern Memorial Hospital,,INTERVENTIONAL,,
NCT00075881,Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma,"Phase II Study of PS-341 for Patients With High-Risk, Newly Diagnosed Multiple Myeloma",COMPLETED,PHASE2,2004-01-01T00:00:00,2012-10-01T00:00:00,2012-10-01T00:00:00,Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma,,National Cancer Institute (NCI),,INTERVENTIONAL,,
